Evaluation of the risk of cervical cancer in patients with Multiple Sclerosis treated with cytotoxic agents: A cohort study.

Rozita Doosti, Mansoureh Togha, Abdorreza Naser Moghadasi, Aida Aghsaie, Amir Reza Azimi, Saeideh Khorramnia, Zahra Moinfar, Fereshteh Ensani, Mohammad Hossein Harirchian, Alireza Minagar,

PubMed · 2018 · 11 citations · 17 references

Full text

Open access

Concepts

Abstract

According to the results of present study, BCC is more frequently observed in patients with MS who were treated with cytotoxic agents with immunosuppressive effect. Since BCC is a 'premalignant condition', the authors suggest that mandatory annual Pap smear should be performed for patients with MS who are treated with cytotoxic agents irrespective of their age in order to detect early signs of malignancy.

References

17